CASP3 and breast cancer: Silencing NOX4 or antioxidant (DPI or NAC) treatment reduced the enhancements in intracellular ROS, cytotoxicity, and caspase-3 activity in KA-treated breast cancer cells, indicating NOX4 as the regulator of KA-induced ROS generation.